Spain María Jesús Lamas, director and César Hernández García, head of medicines for human use at the Spanish Agency of Medicine and Health Products (AEMPS), discuss the challenges impacting the evaluation and analysis of products today. Furthermore, they give insights into why Spain is a leading global clinical trials destination and…
China Dami Qiu, founder and CEO of EMP, shares her personal story of how she decided to establish EMP two decades ago, the market opportunities in ultrasound medical equipment in China, and her groundbreaking poverty alleviation medical devices distribution platform for rural and community hospitals in China, which she hopes to…
Europe Europe accounts for 22.2 percent of global pharma sales; more than Africa, Asia, Australasia, and Latin America combined, but less than half of North America. The biopharmaceutical industry is a key contributor to the European economy in terms of both trade surplus and employment; especially highly-skilled R&D jobs. Germany is…
Pharma This map shows the overall contribution of the pharmaceutical industry to the French economy, including number of employees by region, investment stats, and information on private sector research. Click here to download the latest free pharma report on France.
Pharma The following map shows the importance of the pharmaceutical industry to the highly regionalised Italian industry. Lombardy in the North of Italy employs 27,000 people in pharmaceuticals and is ranked number one for pharma and biotech firms. Click here to read more articles and interviews from Italy, and to download…
Pharma Third generation family member Laure Brenas Baudry explains how CSP has become France’s leading distributor for pharmaceuticals, and how they provide value added services to their large set of clients in over 130 countries. CSP is now the leading French distributor of pharmaceutical products. How has the company grown to…
Pharma The Director of the State Institute for Drug Control in the Czech Republic highlights the Czech pharmaceutical industry as emancipated and points out their tremendous contribution to employment, export balance, the economy at large and to the patients. You assumed the position as interim director of the State Institute for…
Pharma Nanomedicine is expected to become the third pillar of drug development following pharmaceuticals and biologics. The CEO of Dutch contract research and manufacturing organization ChemConnection explains how the company helps customers bring nanomedicine drug delivery systems and APIs from discovery to clinic, fast. Could you please introduce ChemConnection to our…
pharma Nil Tunaşar, managing partner of Transorient, discusses significance of tracking performance metrics among 3PL providers, the organization’s technology overhaul, and also highlights the type of logistics solutions encompassed under Transorient’s Life Sciences and Biopharma line of business. As an introduction for our readers, Nil, please provide some insight into Transorient’s…
Monash University Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region and explains the factors that will make the university a pharmaceutical leader. There is a lot of competition in…
maintenance Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined the business in 1996. The company’s initial vision was to provide flexibility to the maintenance market in Ireland and its…
See our Cookie Privacy Policy Here